459 related articles for article (PubMed ID: 33975634)
1. Deconvolution of cell type-specific drug responses in human tumor tissue with single-cell RNA-seq.
Zhao W; Dovas A; Spinazzi EF; Levitin HM; Banu MA; Upadhyayula P; Sudhakar T; Marie T; Otten ML; Sisti MB; Bruce JN; Canoll P; Sims PA
Genome Med; 2021 May; 13(1):82. PubMed ID: 33975634
[TBL] [Abstract][Full Text] [Related]
2. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient.
Lee HW; Chung W; Lee HO; Jeong DE; Jo A; Lim JE; Hong JH; Nam DH; Jeong BC; Park SH; Joo KM; Park WY
Genome Med; 2020 May; 12(1):47. PubMed ID: 32460812
[TBL] [Abstract][Full Text] [Related]
4. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R; Pietras K
Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
[TBL] [Abstract][Full Text] [Related]
6. Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors.
Davis-Marcisak EF; Fitzgerald AA; Kessler MD; Danilova L; Jaffee EM; Zaidi N; Weiner LM; Fertig EJ
Genome Med; 2021 Aug; 13(1):129. PubMed ID: 34376232
[TBL] [Abstract][Full Text] [Related]
7. Tracking intratumoral heterogeneity in glioblastoma via regularized classification of single-cell RNA-Seq data.
Lopes MB; Vinga S
BMC Bioinformatics; 2020 Feb; 21(1):59. PubMed ID: 32070274
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
Front Immunol; 2021; 12():648917. PubMed ID: 33777046
[No Abstract] [Full Text] [Related]
9. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
[TBL] [Abstract][Full Text] [Related]
10. Biological and Medical Importance of Cellular Heterogeneity Deciphered by Single-Cell RNA Sequencing.
Gupta RK; Kuznicki J
Cells; 2020 Jul; 9(8):. PubMed ID: 32707839
[TBL] [Abstract][Full Text] [Related]
11. Deciphering cell-cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing.
Cao YH; Ding J; Tang QH; Zhang J; Huang ZY; Tang XM; Liu JB; Ma YS; Fu D
Bioengineered; 2022; 13(7-12):14974-14986. PubMed ID: 37105769
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed single-cell transcriptional response profiling to define cancer vulnerabilities and therapeutic mechanism of action.
McFarland JM; Paolella BR; Warren A; Geiger-Schuller K; Shibue T; Rothberg M; Kuksenko O; Colgan WN; Jones A; Chambers E; Dionne D; Bender S; Wolpin BM; Ghandi M; Tirosh I; Rozenblatt-Rosen O; Roth JA; Golub TR; Regev A; Aguirre AJ; Vazquez F; Tsherniak A
Nat Commun; 2020 Aug; 11(1):4296. PubMed ID: 32855387
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell Transcriptomic Analysis of Tumor Heterogeneity.
Levitin HM; Yuan J; Sims PA
Trends Cancer; 2018 Apr; 4(4):264-268. PubMed ID: 29606308
[TBL] [Abstract][Full Text] [Related]
14. Estimation of immune cell content in tumor using single-cell RNA-seq reference data.
Yu X; Chen YA; Conejo-Garcia JR; Chung CH; Wang X
BMC Cancer; 2019 Jul; 19(1):715. PubMed ID: 31324168
[TBL] [Abstract][Full Text] [Related]
15. An Efficient and Flexible Method for Deconvoluting Bulk RNA-Seq Data with Single-Cell RNA-Seq Data.
Sun X; Sun S; Yang S
Cells; 2019 Sep; 8(10):. PubMed ID: 31569701
[TBL] [Abstract][Full Text] [Related]
16. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
Pamarthy S; Sabaawy HE
Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
[TBL] [Abstract][Full Text] [Related]
17. Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing Data.
Davis-Marcisak EF; Sherman TD; Orugunta P; Stein-O'Brien GL; Puram SV; Roussos Torres ET; Hopkins AC; Jaffee EM; Favorov AV; Afsari B; Goff LA; Fertig EJ
Cancer Res; 2019 Oct; 79(19):5102-5112. PubMed ID: 31337651
[TBL] [Abstract][Full Text] [Related]
18. Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing.
Hernández Martínez A; Madurga R; García-Romero N; Ayuso-Sacido Á
Cancer Lett; 2022 Feb; 527():66-79. PubMed ID: 34902524
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing in cancer research.
Zhang Y; Wang D; Peng M; Tang L; Ouyang J; Xiong F; Guo C; Tang Y; Zhou Y; Liao Q; Wu X; Wang H; Yu J; Li Y; Li X; Li G; Zeng Z; Tan Y; Xiong W
J Exp Clin Cancer Res; 2021 Mar; 40(1):81. PubMed ID: 33648534
[TBL] [Abstract][Full Text] [Related]
20. Single-Cell RNA Sequencing for Studying Human Cancers.
Aran D
Annu Rev Biomed Data Sci; 2023 Aug; 6():1-22. PubMed ID: 37040737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
